Loading...

AMGN AMGEN INC Management Changes 8-K Filing

MGN

MGN

AMGEN INC

(AMGN)

2023 8-K

Earnings Release Update

Financial Statements

Financial Statements

Earnings Announcement

Q3 2024 Results

Results of Operations and F...

Annual Meeting of Stockholders

Earnings Press Release

Results of Operations and F...

Results of Operations and F...

Acquisition of Horizon Ther...

Acquisition of Horizon Ther...

Extension of Transaction Ag...

Acquisition and Consent Ord...

Appointment of Certain Offi...

Results of Operations and F...

Acquisition facing litigation

Acquisition on Hold

Acquisition and Complaint

Earnings Press Release

Credit Agreement

Issuance and Sale of Senior...

Underwriting Agreement

Entry into a Material Defin...

External Links:

Amgen Inc. announces the appointment of David M. Reese as Executive Vice President and Chief Technology Officer, and James Bradner as Executive Vice President, Research and Development, and Chief Scientific Officer.

AI Assistant

AMGEN INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.